CART ITEM (0)
report cover

Transthyretin Amyloidosis (ATTR) Market, Global Outlook and Forecast 2023-2030

  • 11 December 2023
  • Life Sciences
  • 68 Pages
  • Report code : 24WT-7873738
sample cover   Download Free PDF sample

Transthyretin Amyloidosis and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Transthyretin Amyloidosis (ATTR) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transthyretin Amyloidosis (ATTR) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transthyretin Amyloidosis (ATTR) Overall Market Size
2.1 Global Transthyretin Amyloidosis (ATTR) Market Size: 2022 VS 2030
2.2 Global Transthyretin Amyloidosis (ATTR) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transthyretin Amyloidosis (ATTR) Players in Global Market
3.2 Top Global Transthyretin Amyloidosis (ATTR) Companies Ranked by Revenue
3.3 Global Transthyretin Amyloidosis (ATTR) Revenue by Companies
3.4 Top 3 and Top 5 Transthyretin Amyloidosis (ATTR) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Transthyretin Amyloidosis (ATTR) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transthyretin Amyloidosis (ATTR) Players in Global Market
3.6.1 List of Global Tier 1 Transthyretin Amyloidosis (ATTR) Companies
3.6.2 List of Global Tier 2 and Tier 3 Transthyretin Amyloidosis (ATTR) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transthyretin Amyloidosis (ATTR) Market Size Markets, 2022 & 2030
4.1.2 Hereditary ATTR (HATTR)
4.1.3 Wild-Type (WT) ATTR
4.2 By Type - Global Transthyretin Amyloidosis (ATTR) Revenue & Forecasts
4.2.1 By Type - Global Transthyretin Amyloidosis (ATTR) Revenue, 2018-2023
4.2.2 By Type - Global Transthyretin Amyloidosis (ATTR) Revenue, 2024-2030
4.2.3 By Type - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transthyretin Amyloidosis (ATTR) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Transthyretin Amyloidosis (ATTR) Revenue & Forecasts
5.2.1 By Application - Global Transthyretin Amyloidosis (ATTR) Revenue, 2018-2023
5.2.2 By Application - Global Transthyretin Amyloidosis (ATTR) Revenue, 2024-2030
5.2.3 By Application - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Transthyretin Amyloidosis (ATTR) Market Size, 2022 & 2030
6.2 By Region - Global Transthyretin Amyloidosis (ATTR) Revenue & Forecasts
6.2.1 By Region - Global Transthyretin Amyloidosis (ATTR) Revenue, 2018-2023
6.2.2 By Region - Global Transthyretin Amyloidosis (ATTR) Revenue, 2024-2030
6.2.3 By Region - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Transthyretin Amyloidosis (ATTR) Revenue, 2018-2030
6.3.2 US Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.3.3 Canada Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.3.4 Mexico Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Transthyretin Amyloidosis (ATTR) Revenue, 2018-2030
6.4.2 Germany Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4.3 France Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4.4 U.K. Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4.5 Italy Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4.6 Russia Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4.7 Nordic Countries Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.4.8 Benelux Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Transthyretin Amyloidosis (ATTR) Revenue, 2018-2030
6.5.2 China Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.5.3 Japan Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.5.4 South Korea Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.5.5 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.5.6 India Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Transthyretin Amyloidosis (ATTR) Revenue, 2018-2030
6.6.2 Brazil Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.6.3 Argentina Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue, 2018-2030
6.7.2 Turkey Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.7.3 Israel Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.7.4 Saudi Arabia Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
6.7.5 UAE Transthyretin Amyloidosis (ATTR) Market Size, 2018-2030
7 Transthyretin Amyloidosis (ATTR) Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Major Product Offerings
7.1.4 Pfizer Transthyretin Amyloidosis (ATTR) Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Company Summary
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.3 Ionis Pharmaceuticals
7.3.1 Ionis Pharmaceuticals Company Summary
7.3.2 Ionis Pharmaceuticals Business Overview
7.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Major Product Offerings
7.3.4 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue in Global Market (2018-2023)
7.3.5 Ionis Pharmaceuticals Key News & Latest Developments
7.4 Corino Therapeutics
7.4.1 Corino Therapeutics Company Summary
7.4.2 Corino Therapeutics Business Overview
7.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Major Product Offerings
7.4.4 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue in Global Market (2018-2023)
7.4.5 Corino Therapeutics Key News & Latest Developments
7.5 Proclara Bioscience
7.5.1 Proclara Bioscience Company Summary
7.5.2 Proclara Bioscience Business Overview
7.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Major Product Offerings
7.5.4 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue in Global Market (2018-2023)
7.5.5 Proclara Bioscience Key News & Latest Developments
7.6 Arcturus Therapeutics
7.6.1 Arcturus Therapeutics Company Summary
7.6.2 Arcturus Therapeutics Business Overview
7.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Major Product Offerings
7.6.4 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue in Global Market (2018-2023)
7.6.5 Arcturus Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Transthyretin Amyloidosis (ATTR) Market Opportunities & Trends in Global Market
Table 2. Transthyretin Amyloidosis (ATTR) Market Drivers in Global Market
Table 3. Transthyretin Amyloidosis (ATTR) Market Restraints in Global Market
Table 4. Key Players of Transthyretin Amyloidosis (ATTR) in Global Market
Table 5. Top Transthyretin Amyloidosis (ATTR) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Transthyretin Amyloidosis (ATTR) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Transthyretin Amyloidosis (ATTR) Product Type
Table 9. List of Global Tier 1 Transthyretin Amyloidosis (ATTR) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transthyretin Amyloidosis (ATTR) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Transthyretin Amyloidosis (ATTR) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Transthyretin Amyloidosis (ATTR) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Transthyretin Amyloidosis (ATTR) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Transthyretin Amyloidosis (ATTR) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Transthyretin Amyloidosis (ATTR) Product Offerings
Table 32. Pfizer Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Alnylam Pharmaceuticals Company Summary
Table 35. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product Offerings
Table 36. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn) & (2018-2023)
Table 37. Alnylam Pharmaceuticals Key News & Latest Developments
Table 38. Ionis Pharmaceuticals Company Summary
Table 39. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product Offerings
Table 40. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn) & (2018-2023)
Table 41. Ionis Pharmaceuticals Key News & Latest Developments
Table 42. Corino Therapeutics Company Summary
Table 43. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product Offerings
Table 44. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn) & (2018-2023)
Table 45. Corino Therapeutics Key News & Latest Developments
Table 46. Proclara Bioscience Company Summary
Table 47. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product Offerings
Table 48. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn) & (2018-2023)
Table 49. Proclara Bioscience Key News & Latest Developments
Table 50. Arcturus Therapeutics Company Summary
Table 51. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product Offerings
Table 52. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue (US$, Mn) & (2018-2023)
Table 53. Arcturus Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Transthyretin Amyloidosis (ATTR) Segment by Type in 2022
Figure 2. Transthyretin Amyloidosis (ATTR) Segment by Application in 2022
Figure 3. Global Transthyretin Amyloidosis (ATTR) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transthyretin Amyloidosis (ATTR) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Transthyretin Amyloidosis (ATTR) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue in 2022
Figure 8. By Type - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 16. US Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 20. Germany Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 21. France Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 28. China Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 32. India Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 34. Brazil Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share, 2018-2030
Figure 37. Turkey Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Transthyretin Amyloidosis (ATTR) Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Transthyretin Amyloidosis (ATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

User License

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

Delivery Time

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

Payment Options

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

Report Delivery

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SIMILAR REPORTS


SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
  • Toshiba
  • yamaha
  • nest
  • hp
  • campbell
  • Deloitte
  • Panasonic
  • sit-group
  • Spirax-Sarco
  • Chevron
  • Zeiss
  • showa denko
  • rolandberger
  • valens
  • harris1
  • mckinsey
  • perkinscoie
  • Saviola
  • gelita
  • Allocatesoft
  • siva-group
  • Chevron
  • Zeiss
  • showa denko
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Transthyretin Amyloidosis and Forecast Market

Leave This Empty: